Profile data is unavailable for this security.
About the company
HighTide Therapeutics Inc is a biopharmaceutical company specializing in the discovery, development and commercialization of multifunctional, multi-targeted therapies for the treatment of metabolic and digestive diseases. The Company has developed a product pipeline of multiple product candidates in-house, covering many indications in metabolic and digestive diseases among which, some are at clinical-stage. The Company’s core product, HTD1801 (berberine ursodeoxycholate), a new molecular entity, is a gut-liver anti-inflammatory metabolic modulator which targets multiple pathways pivotal to metabolic regulation, including those associated with metabolic and digestive diseases. The Company conducts operations in the United States, Mainland China, Hong Kong and Australia.
- Revenue in HKD (TTM)0.00
- Net income in HKD-329.76m
- Incorporated2018
- Employees57.00
- LocationHighTide Therapeutics IncSouth Church Street 103,P.O. Box 10240SHENZHEN 518112ChinaCHN
- Websitehttps://www.hightidetx.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sirnaomics Ltd | 13.90m | -109.55m | 768.78m | 52.00 | -- | -- | -- | 55.32 | -1.33 | -1.33 | 0.161 | -0.3804 | 0.0637 | -- | -- | 201,403.60 | -36.30 | -80.21 | -216.85 | -100.49 | 67.44 | -- | -570.30 | -27,838.86 | -- | -8.20 | -- | -- | -- | -- | 34.70 | -- | -38.10 | -- |
| JW (Cayman) Therapeutics Co Ltd | 201.32m | -699.51m | 941.23m | 292.00 | -- | 0.9141 | -- | 4.68 | -1.69 | -1.69 | 0.4852 | 2.47 | 0.1046 | 1.34 | 9.59 | 716,429.40 | -36.34 | -35.14 | -47.41 | -39.06 | 55.52 | -- | -347.47 | -898.77 | 1.45 | -1,808.42 | 0.2907 | -- | -8.99 | -- | 23.10 | -- | -32.98 | -- |
| Sunho Biologics Inc | 0.00 | -92.97m | 1.00bn | 128.00 | -- | 1.84 | -- | -- | -0.616 | -0.616 | 0.00 | 3.48 | 0.00 | -- | -- | 0.00 | -14.33 | -- | -15.84 | -- | -- | -- | -- | -- | 6.57 | -- | 0.1242 | -- | -- | -- | 39.74 | -- | -- | -- |
| B&K Corp Ltd | 295.61k | -206.83m | 1.09bn | 100.00 | -- | 11.43 | -- | 3,701.60 | -1.76 | -1.76 | 0.0025 | 0.8138 | -- | -- | -- | -- | -- | -- | -- | -- | 92.34 | -- | -69,968.59 | -- | -- | -- | 0.0371 | -- | -44.70 | -- | -101.78 | -- | -- | -- |
| Brii Biosciences Ltd | 0.00 | -425.51m | 1.13bn | 96.00 | -- | 0.3986 | -- | -- | -0.5846 | -0.5846 | 0.00 | 3.91 | 0.00 | -- | -- | 0.00 | -14.05 | -49.92 | -14.09 | -54.57 | -- | -- | -- | -12,750.27 | -- | -- | 0.003 | -- | -100.00 | -- | -190.66 | -- | -33.13 | -- |
| Kintor Pharmaceutical Ltd | 12.44m | -189.22m | 1.39bn | 136.00 | -- | 5.10 | -- | 111.83 | -0.4375 | -0.4375 | 0.0288 | 0.5467 | 0.0194 | 10.66 | 1.06 | 74,049.78 | -29.53 | -47.72 | -44.54 | -55.96 | -55.12 | -36.16 | -1,521.00 | -8,974.73 | 0.4222 | -33.76 | 0.2881 | -- | -- | -- | 85.36 | -- | -53.11 | -- |
| Wuhan YZY Biopharma Co Ltd | 164.23m | -88.38m | 1.40bn | 106.00 | -- | -- | -- | 8.55 | -0.4559 | -0.4559 | 0.8472 | -0.1604 | 0.5805 | 11.54 | 13.96 | 1,453,323.00 | -31.24 | -- | -133.35 | -- | 63.96 | -- | -53.82 | -- | 0.9019 | -24.38 | 1.21 | -- | -- | -- | 49.09 | -- | -- | -- |
| HighTide Therapeutics Inc | 0.00 | -329.76m | 1.49bn | 57.00 | -- | 3.75 | -- | -- | -0.7294 | -0.7294 | 0.00 | 0.6942 | 0.00 | -- | -- | 0.00 | -49.50 | -- | -63.55 | -- | -- | -- | -- | -- | -- | -- | 0.2129 | -- | -- | -- | 59.35 | -- | -- | -- |
| Immunotech Biopharm Ltd | 0.00 | -253.13m | 1.60bn | 173.00 | -- | -- | -- | -- | -0.4523 | -0.4523 | 0.00 | -0.2882 | 0.00 | -- | -- | 0.00 | -37.04 | -36.20 | -186.73 | -45.67 | -- | -- | -- | -- | 0.0712 | -6.63 | 1.48 | -- | -- | -- | 44.18 | -- | 5.95 | -- |
| Cloudbreak Pharma Inc | 78.16m | -326.97m | 1.91bn | 60.00 | -- | -- | -- | 24.47 | -0.3898 | -0.3898 | 0.0932 | -3.08 | -- | -- | -- | 1,532,549.00 | -- | -- | -- | -- | -- | -- | -418.33 | -- | -- | -- | 19.44 | -- | -- | -- | 23.40 | -- | -- | -- |
| ImmuneOnco Biopharmaceuticls Shanghi Inc | 126.96m | -342.81m | 1.98bn | 195.00 | -- | 3.08 | -- | 15.57 | -0.8715 | -0.8715 | 0.3225 | 1.49 | 0.148 | -- | 3,865.48 | 813,859.90 | -40.09 | -- | -51.56 | -- | -- | -- | -270.79 | -- | -- | -- | 0.2236 | -- | 19,109.59 | -- | 16.76 | -- | -- | -- |
| Mabpharm Ltd | 480.14m | -31.12m | 2.10bn | 383.00 | -- | 18.78 | 56.96 | 4.38 | -0.0076 | -0.0076 | 0.1164 | 0.0272 | 0.4209 | 0.4659 | 4.05 | 1,524,243.00 | -2.73 | -19.62 | -4.02 | -25.69 | 86.40 | -- | -6.48 | -211.59 | 0.6906 | -1.58 | 0.7552 | -- | 196.27 | -- | 38.89 | -- | -12.13 | -- |
| Jiangsu Recbio Technology Co Ltd | 12.34m | -740.61m | 2.11bn | 507.00 | -- | 10.29 | -- | 170.98 | -1.55 | -1.55 | 0.0258 | 0.4247 | 0.006 | -- | -- | 23,246.88 | -36.26 | -31.31 | -64.03 | -37.31 | -- | -- | -5,990.59 | -- | 0.2767 | -100.74 | 0.8254 | -- | -- | -- | 1.67 | -- | 16.82 | -- |
| Frontage Holdings Corp | 1.98bn | 29.97m | 2.20bn | 1.54k | 73.11 | 0.8237 | 6.99 | 1.11 | 0.0148 | 0.0148 | 0.9736 | 1.31 | 0.4545 | 60.36 | 3.97 | 1,267,645.00 | 0.6902 | 3.05 | 0.8654 | 3.64 | 27.78 | 32.14 | 1.52 | 6.84 | 1.22 | 1.97 | 0.2861 | 0.00 | -1.90 | 20.48 | -92.68 | -46.72 | 13.29 | -- |
Data as of Feb 13 2026. Currency figures normalised to HighTide Therapeutics Inc's reporting currency: Hong Kong Dollar HKD
0.06%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| SSgA Funds Management, Inc.as of 08 Jan 2026 | 367.50k | 0.06% |
| E Fund Management Co., Ltd.as of 30 Jun 2025 | 0.00 | 0.00% |
| Bosera Asset Management Co., Ltd.as of 30 Jun 2025 | 0.00 | 0.00% |
| Harvest Fund Management Co., Ltd.as of 30 Jun 2025 | 0.00 | 0.00% |
| GF Fund Management Co., Ltd.as of 30 Jun 2025 | 0.00 | 0.00% |
More ▼
Data from 30 Jun 2025 - 12 Feb 2026Source: FactSet Research Systems Inc.
